atorvastatin has been researched along with Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, JS; Armand, P; Asnani, A; Barnes, JA; Brahmbhatt, P; Drobni, ZD; Friedman, RS; Gilman, HK; Han, Y; Heemelaar, JC; Ho, JS; Hochberg, EP; Hua, L; Jacobsen, ED; Jacobson, CA; Januzzi, JL; Jerosch-Herold, M; Kim, AI; Kwong, RY; Ky, B; Lacasce, AS; Landsburg, D; Mahmood, SS; Mousavi, N; Nasta, S; Neilan, TG; Neuberg, DS; Onoue, T; Quinaglia, T; Redd, RA; Sama, S; Scherrer-Crosbie, M; Smith, A; Soumerai, JD; Svoboda, J | 1 |
| Cai, DQ; Kim, CS; Kim, DH; Kim, SK; Lee, KJ; Qi, XF; Qin, JW; Wu, Z; Yu, YH; Zheng, L | 1 |
| Alonso, DF; Farina, HG; Gomez, DE; Hermo, GA | 1 |
| Chang, M; Chen, J; Elchuri, S; Fan, AC; Felsher, DW; Goldstein, MJ; Mitchell, DJ; Nolan, GP; Perez, OD; Shachaf, CM; Sharpe, O; Shirer, AE; Steinman, L; Youssef, S | 1 |
| Favre, G; Leveque, K; Sarrabayrouse, G; Synaeve, C; Tilkin-Mariamé, AF | 1 |
1 trial(s) available for atorvastatin and Lymphoma
| Article | Year |
|---|---|
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Atorvastatin; Cardiovascular Agents; Double-Blind Method; Female; Follow-Up Studies; Heart Diseases; Heart Failure; Humans; Lymphoma; Male; Middle Aged; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2023 |
4 other study(ies) available for atorvastatin and Lymphoma
| Article | Year |
|---|---|
HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
Topics: Acetylcysteine; Acyl Coenzyme A; Animals; Antioxidants; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; DNA Fragmentation; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lymphoma; Membrane Potential, Mitochondrial; Mevalonic Acid; Mice; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Reactive Oxygen Species; Signal Transduction; Simvastatin | 2013 |
Effect of atorvastatin in a case of feline multicentric lymphoma - Case report.
Topics: Animals; Atorvastatin; Cat Diseases; Cats; Chemotherapy, Adjuvant; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphoma; Male; Pyrroles | 2011 |
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
Topics: Animals; Atorvastatin; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Flow Cytometry; Gene Expression Profiling; Glycine; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphoma; Mice; Mice, Transgenic; Mutation; Oncogene Protein p55(v-myc); Phosphoproteins; Phosphorylation; Precancerous Conditions; Pyrroles; ras Proteins; Signal Transduction; Survival Rate | 2007 |
Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; ADP Ribose Transferases; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Atorvastatin; Benzamides; Botulinum Toxins; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphocytes; Lymphoma; Melanoma, Experimental; Membrane Proteins; Methionine; Mevalonic Acid; Mice; Pyrroles; Recombinant Fusion Proteins; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Small Interfering | 2007 |